REA FY18 Revenue of $807.7m, up 20% • EBITDA of $463.7m, up 22%
DHG FY18 Revenue of $357.3m , up 11.5% . EBITDA of $ 115.7 million up 12.5%.
There is scope for DHG to increase its ebitda margins higher towards what REA is achieving.
From the NEC Agm
"A combined Nine and Fairfax supports our plans for Domain’s next phase of growth, allowing us to reach new audiences and improve our ability to deliver the right solutions across the lifelong property journey. "
- Forums
- ASX - By Stock
- NEC
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-10
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.26 |
Change
-0.020(1.56%) |
Mkt cap ! $1.958B |
Open | High | Low | Value | Volume |
$1.30 | $1.31 | $1.26 | $2.056M | 1.608M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 114650 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 16517 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 58112 | 1.675 |
7 | 385906 | 1.670 |
9 | 682264 | 1.665 |
11 | 514339 | 1.660 |
3 | 92052 | 1.655 |
Price($) | Vol. | No. |
---|---|---|
1.685 | 603176 | 14 |
1.690 | 158294 | 11 |
1.695 | 146441 | 3 |
1.700 | 210874 | 12 |
1.705 | 111474 | 5 |
Last trade - 15.59pm 25/11/2024 (20 minute delay) ? |
Featured News
NEC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online